Connection

Maria Re to HIV Protease Inhibitors

Back to Details
This is a "connection" page, showing publications Maria Re has written about HIV Protease Inhibitors.
Maria Re
Connection Strength
0.032
HIV Protease Inhibitors
  1. Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study). Infect Dis (Lond). 2017 Oct; 49(10):737-747.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.